Security Snapshot

First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II (FGM) Institutional Ownership

CUSIP: 33737J190

13F Institutional Holders and Ownership History from Q1 2014 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

26

Shares (Excl. Options)

1,031,434

Price

$62.36

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Type / Class
Equity / First Trust Exchange-Traded AlphaDEX Fund II
Symbol
FGM
Shares outstanding
1,799,956
Price per share
$64.45
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
1,031,434
Total reported value
$64,390,436
% of total 13F portfolios
0%
Share change
+105,540
Value change
+$6,690,737
Number of holders
26
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • FGM - First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II is tracked under CUSIP 33737J190.
  • 26 institutions reported positions in Q4 2025.
  • 1 significant owner is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 26 to 17 between Q4 2025 and Q1 2026.
  • Reported value moved from $64,390,436 to $69,354,459.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 26 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 33737J190?
CUSIP 33737J190 identifies FGM - First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II (FGM) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FIRST TRUST PORTFOLIOS LP 54% +21% $67,120,999 +$25,471,418 977,016 +61% First Trust Portfolios L.P. 28 Feb 2026

As of 31 Dec 2025, 26 institutional investors reported holding 1,031,434 shares of First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II (FGM). This represents 57% of the company’s total 1,799,956 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II (FGM) together control 57% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
FIRST TRUST ADVISORS LP 34% 606,253 +2.1% 0.03% $37,806,664
Arlington Capital Management, Inc. 4.7% 84,859 +64% 3.3% $5,291,909
Kestra Advisory Services, LLC 3% 54,475 +0.5% 0.01% $3,397,149
MEITAV INVESTMENT HOUSE LTD 2.9% 52,000 0% 0.04% $3,242,782
&PARTNERS 2.7% 48,239 0.02% $3,077,213
SUSQUEHANNA INTERNATIONAL GROUP, LLP 2.3% 41,884 +7.1% 0% $2,611,937
JANE STREET GROUP, LLC 2.3% 41,191 +60% 0% $2,568,720
GTS SECURITIES LLC 1.2% 21,473 -34% 0.05% $1,339,078
COTTONWOOD CAPITAL ADVISORS, LLC 1.1% 19,079 +20% 0.85% $1,189,789
RAYMOND JAMES FINANCIAL INC 0.69% 12,481 -2.6% 0% $778,330
Genesee Capital Advisors, LLC 0.57% 10,186 0.26% $635,211
FLOW TRADERS U.S. LLC 0.47% 8,483 -11% 0.02% $529,000
OSAIC HOLDINGS, INC. 0.32% 5,751 +2% 0% $358,555
MORGAN STANLEY 0.32% 5,722 -0.81% 0% $356,840
StoneX Group Inc. 0.27% 4,895 +10% 0.01% $305,257
Transamerica Financial Advisors, LLC 0.25% 4,419 -5.6% 0.02% $275,594
Waverly Advisors, LLC 0.23% 4,161 -14% 0% $259,485
Bright Futures Wealth Management, LLC. 0.18% 3,266 0.15% $203,672
Golden State Wealth Management, LLC 0.06% 1,060 -13% 0.01% $66,143
JPMORGAN CHASE & CO 0.03% 485 0% $30,245
IFP Advisors, Inc 0.02% 402 0% 0% $25,069
Farther Finance Advisors, LLC 0.02% 319 0% 0% $19,893
CREATIVE FINANCIAL DESIGNS INC /ADV 0.01% 200 0% $12,480
FMR LLC 0.01% 123 0% $7,676
ASSETMARK, INC 0% 26 0% $1,621

Institutional Holders of First Trust Exchange-Traded AlphaDEX Fund II - First Trust Exchange-Traded AlphaDEX Fund II (FGM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 1,155,563 $69,354,459 +$15,721,561 $60.02 17
2025 Q4 1,031,434 $64,390,436 +$6,690,737 $62.36 26
2025 Q3 925,894 $54,441,366 +$8,317,548 $58.81 22
2025 Q2 785,878 $44,292,546 +$32,543,175 $56.36 20
2025 Q1 205,757 $9,446,227 +$2,990,051 $45.91 15
2024 Q4 141,862 $5,448,721 -$1,673,784 $38.41 12
2024 Q3 183,335 $7,321,488 +$458,797 $39.93 12
2024 Q2 174,022 $6,430,652 -$2,203,668 $36.89 11
2024 Q1 231,449 $9,260,113 -$2,305,023 $40.10 12
2023 Q4 297,741 $11,571,803 -$4,858,589 $38.89 15
2023 Q3 425,558 $15,407,501 -$6,417,784 $36.20 15
2023 Q2 594,546 $20,427,676 +$11,153,071 $38.84 17
2023 Q1 261,049 $10,141,094 -$5,793,014 $38.26 16
2022 Q4 391,173 $11,512,368 -$1,480,770 $35.32 20
2022 Q3 443,435 $10,650,000 +$1,549,281 $28.31 19
2022 Q2 340,003 $11,545,000 -$3,787,195 $33.73 18
2022 Q1 451,433 $19,768,000 -$56,245,835 $43.90 21
2021 Q4 1,544,294 $82,843,363 -$2,852,350 $53.67 24
2021 Q3 1,508,479 $82,823,000 -$8,343,642 $54.90 22
2021 Q2 1,661,967 $94,793,000 -$631,078 $57.04 23
2021 Q1 1,673,637 $90,068,000 +$2,642,739 $53.82 21
2020 Q4 1,625,405 $83,338,000 +$514,820 $51.28 21
2020 Q3 1,618,896 $71,771,000 -$9,661,346 $44.30 20
2020 Q2 1,844,301 $74,686,681 -$12,541,585 $40.50 20
2020 Q1 2,154,255 $67,439,695 -$31,606,893 $31.31 22
2019 Q4 3,098,549 $137,572,832 +$5,877,890 $44.42 30
2019 Q3 2,966,613 $118,459,000 -$14,979,708 $39.94 29
2019 Q2 3,347,482 $140,056,000 -$5,863,726 $41.83 33
2019 Q1 3,521,722 $145,118,000 +$10,033,368 $41.20 32
2018 Q4 3,278,824 $123,562,000 -$43,138,734 $37.69 32
2018 Q3 4,421,908 $204,831,000 -$20,984,368 $46.33 34
2018 Q2 4,876,191 $224,682,000 +$125,461 $46.07 33
2018 Q1 4,870,534 $243,421,488 +$7,686,582 $49.98 32
2017 Q4 4,712,252 $241,206,256 +$18,934,829 $51.20 33
2017 Q3 4,350,513 $207,826,102 +$17,894,027 $47.78 31
2017 Q2 4,002,572 $173,507,311 +$21,049,737 $43.35 36
2017 Q1 3,511,408 $138,772,885 +$39,672,983 $39.53 34
2016 Q4 2,490,595 $90,536,172 -$16,853,214 $36.35 26
2016 Q3 2,976,363 $111,585,554 -$15,642,677 $37.49 28
2016 Q2 3,398,719 $117,553,728 -$4,522,039 $34.59 27
2016 Q1 3,526,876 $129,064,625 -$51,729,830 $36.60 26
2015 Q4 4,942,929 $178,968,134 -$11,687,200 $36.21 28
2015 Q3 5,268,815 $177,195,780 -$51,308,281 $33.63 28
2015 Q2 6,787,901 $257,219,572 +$188,207,092 $37.89 27
2015 Q1 1,820,460 $69,851,922 +$16,718,190 $38.37 21
2014 Q4 1,294,695 $46,585,251 +$9,001,561 $35.98 19
2014 Q3 1,053,008 $37,130,068 -$2,356,839 $35.27 19
2014 Q2 1,119,413 $46,795,426 +$4,721,768 $41.81 22
2014 Q1 1,002,365 $42,469,914 +$2,658,692 $42.36 20
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .